Consider switching to insulin & other therapies Some patients established on GLP-1 RA therapy for type 2 diabetes may need to be switched to alternative treatments including insulin
Zepbound (Tirzepatide Injection) As an FDA-approved injectable form of tirzepatide for weight loss, Zepbound is administered weekly via subcutaneous injection
Step 3 Medication Delivery: If a prescription is written, the medication is dispensed by a partner pharmacy and shipped to the consumer's door
Patients with certain genetic profiles may reach their weight loss goal at 1.7 mg, while others with different variants benefit from advancing to 2.4 mg or adding a second compound
For others, it may not be a conscious decision to stop taking a medication
Methods Trial design This was a single-centre, randomised, multiple-dose, double-blind, placebo-controlled, parallel-group trial in participants with type 2 diabetes